Dialog Box

Tissue & Clinical Annotation Working Group

Key Objectives: 

  • Optimise sample acquisition and quality metrics and develop standardisations for data e.g. clinical nomenclature and depth
  • Define metrics around cohorts that satisfy requirements
  • Define clinical metrics and implications of germline variants, which impact on risk, therapeutic response and toxicity.


Working Group Leader(s) Name Institution and contact:

Peter Lichter, PhD

Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany

Peter Lichter studied at the University of Heidelberg (Germany) and graduated with a PhD from the Max Planck Institute for Medical Research, Division Molecular Biology, Heidelberg. After a postdoc phase at Yale University, New Haven (USA) he joined the German Cancer Research Center in Heidelberg and is head of the division of Molecular Genetics. 

He has been an active member of ICGC from its very beginning in 2008 heading the Tissue and Clinical Annotation working group and coordinating the very successful ICGC-PedBrainTumor project that focussed on pediatric brain tumors.

Overall, Peter Lichter and his group made important contributions to understanding the molecular processes responsible for the etiology and development of cancer. In a number of cases, he has co-initiated precision oncology registry studies in collaboration with clinical partners, successfully translating the results into clinical practice.

Working Group Contact: 

Ursula Weber

The German Cancer Research Centre, Germany

Email - u.weber@Dkfz-Heidelberg.de


Current Membership List:

Name

Institution

Country

Peter Lichter

Federal Ministry of Education and Research: German Cancer Aid

Germany

Hardeep Nahal-Bose

Ontario Institute for Cancer Research

Canada

Christian Chabannon

Institut National du Cancer

France

Lynda Chin

National Institutes of Health

USA

Bruno Clement

Institut National du Cancer

France

Enrique de Alava

Spanish Ministry of Science and Innovation

Spain

Francoise Degos

Institut National du Cancer

France

Martin Ferguson

National Institutes of Health

USA

Julie Gastier-Foster

National Institutes of Health

USA

Patricia Harnden

European Commission

France

Neil Hayes

National Institutes of Health

USA

Michael Hummel

Federal Ministry of Education and Research

Germany

Amber Johns

Garvan Institute of Medical Research

Australia

Robert Penny

National Institutes of Health

USA

Miguel Angel Piris

Spanish Ministry of Science and Innovation

Spain

Rajiv Sarin

Department of Biotechnology, Ministry of Science & Technology

India

Aldo Scarpa

University of Verona, Italian Ministry of Education, University and Research

Italy

Tatsuhiro Shibata

National Cancer Center

Japan

Hidewaki Nakagawa

RIKEN: NiBio

Japan

Marc van de Vijver

European Commission

United Kingdom



Donate